Use tibolone (livial) at patients with klimacteric cardiopathie
L. L. Bobrov , S. V. Dudarenko , A. G. Qbrezan
Journal of obstetrics and women's diseases ›› 1997, Vol. 46 ›› Issue (1) : 44 -48.
Use tibolone (livial) at patients with klimacteric cardiopathie
In operation own data and analytical arguing about possibility of application replacement hormonal of therapy (RHT) Livial at patients with climacteric cardiopathies are represented. In an outcome of researches is installed, that Livial promotes improving systole of myocard and reduces a degree it hypertrophy; normalization intracardial and intravascular bloodstream, improving active activw relaxing of the left ventricle and rise of elasticity large artery’s. The tendency to normalization, and on early stages climacteric climacteric hypertension - normalization arterial of pressure, and also - improving trofics of the myocard, rise of its electrical stability and lowering arithmogenic is observed; an amplification anticoagulation and lowering procoagulation of a potential of blood with improving oj microcirculation. Obtained data specify validity and necessity RHT of Livial at the women with climacteric cardiopathies.
hormone therapy with tibolone / climacteric cardiopathy / tibolone
| [1] |
Грацианский Н.А.// Клин. Фармакол. и Тер. - 1994. - №3.-С. 30-39. |
| [2] |
Williams J.К.// Lancet. - 1993. - Vol. 343. - Р. IS8. |
| [3] |
Riedel М., MuggeA.,Lippolt P. et al.// Z. Kardiol. — 1993.Vol. 82, №1. - P. 148. |
| [4] |
Rosano G.M.C., Sarrel Ph.M., Poole-Wilson Ph.A., Collins P. // Lancet. - 1993. - Vol. 342.P. 133-136. |
| [5] |
Manolio T.A., Furberg C.D., Shemanski et al.//Circulat. - 1993.Vol. 88, № I. - P. 2163-2171. |
| [6] |
Sullivan J., El-Zeky F., Zwaag R. V., Ramanathan K.J.// Am. Coll. Cardiol. 1994. -№ 3. - P. 45-56. |
| [7] |
Sitruk- Ware R.//Drugs. - 1990. Vol.39. - P.203-217. |
| [8] |
David M., Griesmacher A., Muller M.M.//Prostaglandins. - 1989- Vol. 38-P. 431-438. |
| [9] |
Kloosterboer H.J., Benedek-Jaszmann K.J., Kicovic P.M.// Maturitas. - 1990. Vol.12.-P. 37-42. |
| [10] |
Manolio T.A., Furberg C.D., Shemanski et al.//Circulat. - 1993. Vol. 88, № I. - P. 2163-2171. |
| [11] |
Boschetti C., Cortellaro M., Nencioni T. et al.//Thromb. Res. 1991- Vol. 62.-P. 1-8. |
| [12] |
Ramwell P., Rubanyi G., Schillinger E. Sex steroids and the cardiovascular system. — Berlin., 1992 - P. 200. Magness R.R., Rosenfeld C.R.// Fm. Physiol. - 1989. - Vol. 256, № 1. -P. E536 - E542. |
| [13] |
Матюшин A. И., Левандовский И.В.// Экспер. и Клин. Фармакол.-1994. - № 6. -С. 29-31. |
| [14] |
Lin A.L., Gonsalez R.Jr., Carey K.D., Shaim S.A.//Arteriosclerosis. — 1986. - № 6. - P. 495-504. |
| [15] |
Horwitz K. W., Horwitz L.D.// J.Clin. Invest. — 1982. — Vol. 69.P. 750 - 758. |
| [16] |
Сергеев П.В., Шимановский Н.Л. Рецепторы физиологически активных веществ.-М., Мед. 1987. - С. 201. |
| [17] |
Лукьянова Л.Д., Елисеев Р.А., Макаренко Т.Н., Матюшин А.И. // Бюлл. Экспер. Биол. и Мед.1994 - № 12.-С. 616-618. |
| [18] |
Кобрин В.И., Игнатова Е.Д., Балякин Ю. В.Бюлл. Экспер. Биол. и Мед. 1993- № 5.-С. 486-487. |
| [19] |
Raddino R., Poli E.,Pela G., Manca C. // Int. J. Exp. Clin. Pharmacol. - 1989. - Vol. 38. P. 185-190. |
| [20] |
Collins P., Rosano G.M.C., Jiang C. et al.//Lancet. - 1993.Vol. 341. - P. 1264 - 1265. |
| [21] |
P. Hardiman, P. Nihoyannopoulos, P. Kicovic.,J.Ginsburg. //Maturitas. - 1991.Vol. 13.-P. 235- 242. |
| [22] |
Кобрин В.И., Маноах M., Гольдберг Г. и др.// Бюлл.Экспер. Биол. и Мед. - 1995.№5. - С. 386 - 387. |
Eсо-Vector
/
| 〈 |
|
〉 |
PDF
